These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27083991)

  • 1. Blood compatibility assessment of polymers used in drug eluting stent coatings.
    Szott LM; Irvin CA; Trollsas M; Hossainy S; Ratner BD
    Biointerphases; 2016 Jun; 11(2):029806. PubMed ID: 27083991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
    Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of stent surface on thrombogenicity and vascular healing: a comparative analysis of metallic and polymeric surfaces.
    Eppihimer MJ; Sushkova N; Grimsby JL; Efimova N; Kai W; Larson S; Forsyth B; Huibregtse BA; Dawkins KD; Wilson GJ; Granada JF
    Circ Cardiovasc Interv; 2013 Aug; 6(4):370-7. PubMed ID: 23899869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of chemical stability of polymers of XIENCE everolimus-eluting coronary stents in vivo by pyrolysis-gas chromatography/mass spectrometry.
    Kamberi M; Pinson D; Pacetti S; Perkins LEL; Hossainy S; Mori H; Rapoza RJ; Kolodgie F; Virmani R
    J Biomed Mater Res B Appl Biomater; 2018 Jul; 106(5):1721-1729. PubMed ID: 28884951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
    Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
    Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro blood and vascular compatibility of sirolimus-eluting organic/inorganic hybrid stent coatings.
    Jang TS; Cheon KH; Ahn JH; Song EH; Kim HE; Jung HD
    Colloids Surf B Biointerfaces; 2019 Jul; 179():405-413. PubMed ID: 30999119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
    Pan CJ; Tang JJ; Shao ZY; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):105-11. PubMed ID: 17540543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo.
    Alviar CL; Tellez A; Wang M; Potts P; Smith D; Tsui M; Budzynski W; Raizner AE; Kleiman NS; Lev EI; Granada JF; Kaluza GL
    J Thromb Thrombolysis; 2012 Jul; 34(1):91-8. PubMed ID: 22350685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of blood-material interaction and drug eluting stent polymers in review.
    Mori H; Gupta A; Torii S; Harari E; Jinnouchi H; Virmani R; Finn AV
    Expert Rev Med Devices; 2017 Sep; 14(9):707-716. PubMed ID: 28770625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings.
    Chin-Quee SL; Hsu SH; Nguyen-Ehrenreich KL; Tai JT; Abraham GM; Pacetti SD; Chan YF; Nakazawa G; Kolodgie FD; Virmani R; Ding NN; Coleman LA
    Biomaterials; 2010 Feb; 31(4):648-57. PubMed ID: 19822362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions.
    Hou R; Wu L; Wang J; Yang Z; Tu Q; Zhang X; Huang N
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent.
    Granada JF; Alviar CL; Wallace-Bradley D; Osteen M; Dave B; Tellez A; Win HK; Kleiman NS; Kaluza GL; Lev EI
    J Thromb Thrombolysis; 2010 Jan; 29(1):60-9. PubMed ID: 19466381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable, elastomeric coatings with controlled anti-proliferative agent release for magnesium-based cardiovascular stents.
    Gu X; Mao Z; Ye SH; Koo Y; Yun Y; Tiasha TR; Shanov V; Wagner WR
    Colloids Surf B Biointerfaces; 2016 Aug; 144():170-179. PubMed ID: 27085049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial.
    Smits PC; Hofma S; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; Vuillomenet A; Serra A; Nouche RT; den Heijer P; van der Ent M
    Lancet; 2013 Feb; 381(9867):651-60. PubMed ID: 23374650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
    Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
    Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro assays of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor monoclonal antibody.
    Yin T; Wang G; Ruan C; Guzman R; Guidoin R
    J Biomed Mater Res A; 2007 Dec; 83(3):861-7. PubMed ID: 17567855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents.
    Jinnouchi H; Kutyna M; Torii S; Cheng Q; Sakamoto A; Guo L; Cornelissen A; Perkins LEL; Hossainy SF; Pacetti SD; Kolodgie FD; Virmani R; Finn AV
    EuroIntervention; 2021 Jun; 17(3):248-256. PubMed ID: 32149708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.